"Fulminant" Behçet disease

Presse Med. 2011 Nov;40(11):1087-9. doi: 10.1016/j.lpm.2011.04.004. Epub 2011 Jun 11.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Adolescent
  • Anti-Inflammatory Agents / administration & dosage
  • Antibodies, Monoclonal / administration & dosage
  • Atrophy
  • Azathioprine / administration & dosage
  • Behcet Syndrome / diagnosis*
  • Behcet Syndrome / drug therapy
  • Behcet Syndrome / immunology
  • C-Reactive Protein / analysis
  • Cyclophosphamide / administration & dosage
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Emigrants and Immigrants*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Infliximab
  • Infusions, Intravenous
  • Magnetic Resonance Imaging
  • Methylprednisolone / administration & dosage
  • Myelitis, Transverse / diagnosis
  • Myelitis, Transverse / drug therapy
  • Myelitis, Transverse / immunology
  • Neurologic Examination
  • Phenindione / administration & dosage
  • Phenindione / analogs & derivatives
  • Prednisolone / administration & dosage
  • Pyoderma Gangrenosum / drug therapy
  • Spinal Cord / pathology
  • Spinal Cord Ischemia / diagnosis
  • Spinal Cord Ischemia / drug therapy
  • Spinal Cord Ischemia / immunology
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Phenindione
  • Cyclophosphamide
  • C-Reactive Protein
  • Prednisolone
  • Infliximab
  • fluindione
  • Azathioprine
  • Methylprednisolone